A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse population.

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as it was." ...

NAIROBI, Kenya — A court in Kenya on Friday suspended a U.S. plan to establish a quarantine facility for Americans exposed to a rare type of Ebola virus spreading in northeastern Congo, following a ...

Kuppalli is an infectious diseases physician in Dallas. As the FIFA World Cup approaches, speculation on social media and cable news has already begun: Could Ebola spread at the tournament? The short ...

Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.

CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions ...

That’s how many patients with Covid-19 go on to develop long Covid, according to a study of nearly 458,000 patients at 58 hospitals, published yesterday in JAMA Network Open. It’s about twice the rate ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

President Trump had another medical exam on Tuesday, putting his health under renewed public scrutiny after he has worked to ...